Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study to Evaluate Efficacy and Safety of Different Formulations of Fenticonazole + Tinidazole + Lidocaine in the Treatment of Bacterial Vaginosis, Candidal Vulvovaginitis, Trichomonal Vaginitis and Mixed Infections

NCT06056947 is registered in ClinicalTrials.gov with Ege University as lead sponsor.

NCT NCT06056947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06056947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study to Evaluate Efficacy and Safety of Different Formulations of Fenticonazole + Tinidazole + Lidocaine in the Treatment of Bacterial Vaginosis, Candidal Vulvovaginitis, Trichomonal Vaginitis and Mixed Infections
Lead sponsor
Ege University
Phase
Phase 3
Overall status
Completed
Start date
July 20, 2020
Completion date
August 26, 2021
Enrollment
577 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, candidal vulvovaginitis, mixed vaginal infections, trichomonal vaginitis